• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌筛查。过去的成就与未来的挑战。

Cervical cancer screening. Past success and future challenge.

作者信息

Dewar M A, Hall K, Perchalski J

机构信息

Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville.

出版信息

Prim Care. 1992 Sep;19(3):589-606.

PMID:1410065
Abstract

Population screening for cervical cancer resulted in significant reduction in the morbidity and mortality from cervical cancer. An increased understanding of the relationship of HPV infection with cervical cancer and the natural history of cervical cancer precursor lesions further solidifies and expands the biological basis for cervical cancer screening. Pap tests in asymptomatic women remain the cornerstone of cervical cancer screening. Clinicians should be cognizant of the significant false-negative rate of Pap smears. Meticulous attention to proper Pap smear technique is necessary to maximize the sensitivity of the test. Further research is needed to establish the role of cervicography and HPV DNA hybridization techniques in cervical cancer screening.

摘要

宫颈癌的人群筛查显著降低了宫颈癌的发病率和死亡率。对人乳头瘤病毒(HPV)感染与宫颈癌关系以及宫颈癌前病变自然史的进一步了解,进一步巩固和拓展了宫颈癌筛查的生物学基础。对无症状女性进行巴氏试验仍然是宫颈癌筛查的基石。临床医生应认识到巴氏涂片存在显著的假阴性率。必须严格注意正确的巴氏涂片技术,以最大限度提高检测的敏感性。还需要进一步研究以确定宫颈图像检查和HPV DNA杂交技术在宫颈癌筛查中的作用。

相似文献

1
Cervical cancer screening. Past success and future challenge.宫颈癌筛查。过去的成就与未来的挑战。
Prim Care. 1992 Sep;19(3):589-606.
2
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.筛查可预防的宫颈癌风险:来自瑞典全国性审计的证据。
J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29.
3
Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.巴氏涂片检查后浸润性宫颈癌的风险:多次阴性结果的保护作用。
J Med Screen. 2005;12(1):7-11. doi: 10.1258/0969141053279103.
4
Risk factors for cervical neoplasia in Denmark.丹麦宫颈癌前病变的危险因素。
APMIS Suppl. 1998;80:1-41.
5
[Cancer of the cervix, papillomavirus, contraception and tobacco].[宫颈癌、乳头瘤病毒、避孕与烟草]
J Gynecol Obstet Biol Reprod (Paris). 1993;22(5):477-86.
6
Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.人乳头瘤病毒(HPV)检测与传统及自动化辅助巴氏涂片筛查作为预防宫颈癌潜在筛查工具的比较。
BJOG. 2004 Aug;111(8):842-8. doi: 10.1111/j.1471-0528.2004.00210.x.
7
[How technology and vaccination have changed the Pap test].[技术与疫苗接种如何改变了巴氏试验]
Pathologica. 1999 Feb;91(1):36-41.
8
HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.在罹患宫颈癌的女性中,人乳头瘤病毒(HPV)的存在先于细胞学异常,并提示涂片检查假阴性。
Br J Cancer. 2001 Aug 3;85(3):398-404. doi: 10.1054/bjoc.2001.1926.
9
1991 cervical screening recommendations: a working group report.
N Z Med J. 1991 Jul 10;104(915):291-5.
10
A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.一项关于鳞状细胞癌和腺癌筛查的瑞典纵向研究:有效性和过度治疗的证据。
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2641-8. doi: 10.1158/1055-9965.EPI-07-0278.

引用本文的文献

1
Advancements in Cervical Cancer Screening: Enhancing HPV Testing and Triage Strategies for Improved Risk Assessment.宫颈癌筛查的进展:加强人乳头瘤病毒检测及分流策略以改善风险评估
Biomedicines. 2025 Jul 18;13(7):1768. doi: 10.3390/biomedicines13071768.
2
Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies.人乳头瘤病毒与宫颈癌:对发病机制及靶向治疗策略的深入剖析
Virusdisease. 2022 Jun;33(2):132-154. doi: 10.1007/s13337-022-00768-w. Epub 2022 May 30.
3
Trends in Solid Tumor Incidence in Ukraine 30 Years After Chernobyl.
切尔诺贝利事故30年后乌克兰实体瘤发病率的趋势
J Glob Oncol. 2019 Aug;5:1-10. doi: 10.1200/JGO.19.00099.
4
Cost-effective policies for cervical cancer screening. An international review.宫颈癌筛查的成本效益政策。一项国际综述。
Pharmacoeconomics. 1996 Mar;9(3):211-30. doi: 10.2165/00019053-199609030-00004.